I think the fundamental principle for all regulated industry whether it be biopharmaceuticals, medical devices, is that scientific concepts do not result in products for

Risk is still an important issue, and the fundamental premise is that there is so much to do. The science is so complex. The regulatory

What are some of the common issues and trends you are hearing from biopharmaceutical executives? There were trends that were occurring before the COIVID crisis,